Genomenon is a RWE and genomics intelligence company helping pharmaceutical and clinical diagnostics companies to inform precision medicine efforts and accelerate patient diagnosis by unlocking real-world evidence from biomedical literature. Our unique AI, combined with insights from our team of genomic experts empowers precision therapeutic companies to optimize clinical trial design, enhance diagnostic patient yield, and streamline regulatory submissions.